Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers-Reference-Cited by-同舟云学术

Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers

Published:2022-04 Issue: Volume:43 Page:101375
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Simon Johanna,Fichter Michael,Kuhn Gabor,Brückner Maximilian,Kappel Cinja,Schunke Jenny,Klaus Tanja,Grabbe Stephan,Landfester Katharina,Mailänder Volker

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference57 articles.

1. Structural absorption by barbule microstructures of super black bird of paradise feathers

2. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

3. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design

4. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

5. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions;Cancers;2024-05-27

2. Application of nanomaterials in heart transplantation: a narrative review;Journal of Thoracic Disease;2024-05

3. RNA nanostructures for targeted drug delivery and imaging;RNA Biology;2024-03-31

4. Immunoactivity of a hybrid membrane biosurface on nanoparticles: enhancing interactions with dendritic cells to augment anti-tumor immune responses;Biomaterials Science;2024

5. Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy;ACS Nano;2023-12-06